GPC3_HUMAN - dbPTM
GPC3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GPC3_HUMAN
UniProt AC P51654
Protein Name Glypican-3
Gene Name GPC3
Organism Homo sapiens (Human).
Sequence Length 580
Subcellular Localization Cell membrane
Lipid-anchor, GPI-anchor
Extracellular side.
Secreted glypican-3: Secreted, extracellular space.
Protein Description Cell surface proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition..
Protein Sequence MAGTVRTACLVVAMLLSLDFPGQAQPPPPPPDATCHQVRSFFQRLQPGLKWVPETPVPGSDLQVCLPKGPTCCSRKMEEKYQLTARLNMEQLLQSASMELKFLIIQNAAVFQEAFEIVVRHAKNYTNAMFKNNYPSLTPQAFEFVGEFFTDVSLYILGSDINVDDMVNELFDSLFPVIYTQLMNPGLPDSALDINECLRGARRDLKVFGNFPKLIMTQVSKSLQVTRIFLQALNLGIEVINTTDHLKFSKDCGRMLTRMWYCSYCQGLMMVKPCGGYCNVVMQGCMAGVVEIDKYWREYILSLEELVNGMYRIYDMENVLLGLFSTIHDSIQYVQKNAGKLTTTIGKLCAHSQQRQYRSAYYPEDLFIDKKVLKVAHVEHEETLSSRRRELIQKLKSFISFYSALPGYICSHSPVAENDTLCWNGQELVERYSQKAARNGMKNQFNLHELKMKGPEPVVSQIIDKLKHINQLLRTMSMPKGRVLDKNLDEEGFESGDCGDDEDECIGGSGDGMIKVKNQLRFLAELAYDLDVDDAPGNSQQATPKDNEISTFHNLGNVHSPLKLLTSMAISVVCFFFLVH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MAGTVRTACLV
----CCCHHHHHHHH
9.4026853621
25Pyrrolidone_carboxylic_acidLDFPGQAQPPPPPPD
CCCCCCCCCCCCCCC
43.0529345911
50UbiquitinationQRLQPGLKWVPETPV
HHHCCCCCCCCCCCC
52.6521906983
124N-linked_GlycosylationIVVRHAKNYTNAMFK
HHHHHHHHHHHHHHH
50.0429345911
241N-linked_GlycosylationNLGIEVINTTDHLKF
HHCCEEEECCCCCHH
41.9429345911
242PhosphorylationLGIEVINTTDHLKFS
HCCEEEECCCCCHHC
23.6027174698
243PhosphorylationGIEVINTTDHLKFSK
CCEEEECCCCCHHCH
19.5527174698
299PhosphorylationIDKYWREYILSLEEL
HHHHHHHHHHCHHHH
9.89-
311PhosphorylationEELVNGMYRIYDMEN
HHHHCCCHHHHCHHH
8.68-
342 (in isoform 3)Phosphorylation-25.94-
343 (in isoform 3)Phosphorylation-27.18-
344 (in isoform 3)Phosphorylation-23.61-
346 (in isoform 3)Phosphorylation-18.13-
352PhosphorylationIGKLCAHSQQRQYRS
HHHHHHHHHHHHHHH
14.9610814714
359O-linked_GlycosylationSQQRQYRSAYYPEDL
HHHHHHHHCCCCHHH
18.7155833519
388UbiquitinationEETLSSRRRELIQKL
HHHHHHHHHHHHHHH
38.0721890473
418N-linked_GlycosylationSHSPVAENDTLCWNG
CCCCCCCCCCCCCCH
37.5229345911
442UbiquitinationKAARNGMKNQFNLHE
HHHHCCCCCCCCHHH
49.3321890473
465UbiquitinationVVSQIIDKLKHINQL
HHHHHHHHHHHHHHH
49.37-
465UbiquitinationVVSQIIDKLKHINQL
HHHHHHHHHHHHHHH
49.3721890473
465UbiquitinationVVSQIIDKLKHINQL
HHHHHHHHHHHHHHH
49.3721890473
495O-linked_GlycosylationLDEEGFESGDCGDDE
CCCCCCCCCCCCCCC
37.36-
509O-linked_GlycosylationEDECIGGSGDGMIKV
CCCCCCCCCCCCHHH
28.62-
554GPI-anchorNEISTFHNLGNVHSP
CCCCCCCCCCCCCCH
45.51-
571PhosphorylationLLTSMAISVVCFFFL
HHHHHHHHHHHHHHH
10.04-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
352SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GPC3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GPC3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FGF2_HUMANFGF2physical
12478660

Drug and Disease Associations
Kegg Disease
H00048 Hepatocellular carcinoma
H00493 Heparan sulfate proteoglycan gene defects, including: Dyssegmental dysplasia, Silverman-Handmaker ty
H01215 Simpson-Golabi-Behmel syndrome (SGBS)
OMIM Disease
312870Simpson-Golabi-Behmel syndrome 1 (SGBS1)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GPC3_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP